As per MRFR analysis, the US Tissue Banking Market Size was estimated at 357.7 (USD Million) in 2023. The US Tissue Banking Market Industry is expected to grow from 390(USD Million) in 2024 to 1,070 (USD Million) by 2035. The US Tissue Banking Market CAGR (growth rate) is expected to be around 9.609% during the forecast period (2025 - 2035).
The US Tissue Banking Market is experiencing several important trends shaped by advancements in medical technology and societal needs. One prominent driver of this market is the increasing demand for organ transplantation and regenerative medicine, which necessitates a reliable supply of tissues and cells. This demand is further fueled by the growing awareness of tissue banking benefits, leading to more individuals enrolling as donors.
Efforts from organizations like the U.S. Department of Health and Human Services aim to enhance public understanding of the importance of tissue donation, contributing to increased donor numbers. Recent times have witnessed a surge in the collaboration between tissue banks and healthcare institutions. This trend is essential for improving access to stored tissues and optimizing usage in clinical settings. Additionally, there is a growing focus on ethical practices concerning tissue collection and storage, with regulatory bodies emphasizing transparency and patient consent.
New technologies, such as biobanking informatics, are being implemented to streamline the management of tissue samples, improving efficiency and traceability. The market also presents numerous opportunities, particularly in the development of personalized medicine. As advancements in genomics progress, there is a potential for tissue banks to provide tailored therapies that enhance treatment outcomes for patients.
Moreover, there is a trend of expanding the applications of stored tissues in research and drug development, which could further drive the market. As the landscape of healthcare continues to evolve, the US Tissue Banking Market is well-positioned to adapt and grow, responding to both consumer needs and technological advancements.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Tissue Banking Market Industry is experiencing significant growth driven by the increase in organ transplantation procedures. According to the United States Department of Health and Human Services, over 39,000 organ transplants were performed in 2020, marking a 5% increase from the previous year. The rise in demand for organs and tissues for transplant reflects the growing prevalence of chronic diseases and aging populations, driving hospitals and medical institutions to collaborate with tissue banks to obtain necessary biological materials.
Additionally, organizations like the American Association of Tissue Banks are instrumental in promoting effective tissue donation and transplantation practices, further bolstering the market's growth. This rising number of procedures translates to a direct increase in the demand for tissue banking services, propelling an estimated growth in the market as health authorities place a greater emphasis on donor registries and public awareness campaigns to enhance organ donation rates.
Recent advancements in regenerative medicine are significantly influencing the US Tissue Banking Market Industry. The National Institutes of Health reports that the field of regenerative medicine is expected to reach USD 43 billion by 2025, fueled by innovations in stem cell research and tissue engineering. These advancements are driving demand for high-quality biological tissues and cells, which tissue banks supply.
Furthermore, institutions like the National Stem Cell Foundation are actively involved in developing therapies that utilize stem cells and tissue engineering technologies, necessitating reliable and ethically sourced tissue banks for research and clinical applications. As more therapeutic techniques emerge in regenerative medicine, the need for robust tissue banking infrastructures will undoubtedly escalate, signaling positive growth prospects for the industry.
Public awareness campaigns about tissue donation have gained momentum in the US, fostering an environment conducive to the growth of the US Tissue Banking Market Industry. Organizations such as Donate Life America have launched extensive educational initiatives to highlight the importance of tissue donation, impacting donor registrations positively.
Data from the Department of Transportation indicates that registered organ and tissue donors increased by 25% over the last five years, showing heightened public interest in contributing to tissue banks. This rise in public awareness directly correlates to increased tissue donations that benefit multiple medical procedures, creating a more stable supply for the market. As communities become increasingly aware of the life-saving potential of tissue donation, the demand for services offered by tissue banks continues to surge, presenting substantial opportunities for growth within the industry.
The US Tissue Banking Market, particularly within the Type segment, showcases a diverse range of essential components designed to enhance tissue preservation and quality control. This market is characterized by several key categories, including Media and Consumable, Cryopreservation Equipment, Thawing Equipment, Quality Control Equipment, and Others. The Media and Consumable segment is critical as it provides the necessary solutions for maintaining the viability of tissues, thus facilitating successful transplantation and research applications.
Cryopreservation Equipment plays a significant role in the market by ensuring the safe storage of biological samples at low temperatures, which is essential for long-term preservation and later use. Meanwhile, Thawing Equipment is pivotal as it directly impacts the recovery and success rates of stored specimens. Quality Control Equipment is equally important as it ensures adherence to stringent regulatory standards, thereby reinforcing the reliability of tissue banking operations.
In addition to these, various other components contribute to a robust ecosystem that supports advancements in research and therapeutic applications. Factors driving growth within this segment include increasing demand for organ transplants, advancements in regenerative medicine, and the rising prevalence of chronic diseases in the US. As a result, this market is poised for significant growth, reflecting the ongoing investments in medical research and development.
Moreover, ongoing technological innovations in cryopreservation and increased awareness about the importance of tissue banking are propelling further growth within the US Tissue Banking Market. Overall, the Type segment of the US Tissue Banking Market is a dynamic and promising area of development, reflecting a strong demand for improved health outcomes and enhanced medical research capabilities.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Tissue Banking Market segment focused on Tissue Type plays a crucial role in advancing medical procedures and improving patient outcomes. Various types include Heart Valves, Corneas, Bones, Skin, and Brain and Spinal Cord tissues, each serving specific medical needs. For instance, heart valves are vital for patients requiring cardiac surgeries, and their availability significantly influences surgical outcomes and recovery times.
Corneas are essential for treating visual impairments, while bone and skin tissues are crucial for reconstructive surgeries and trauma care, responding to the increasing demand for transplantable tissues. Moreover, brain and spinal cord tissues contribute to neuroscience research and treatment developments related to neurodegenerative diseases.
The diversity within this segment provides a significant foundation for the broader US Tissue Banking Market, highlighting its importance in healthcare advancements, underlining its potential and necessity in supporting various treatment modalities and enhancing life quality for countless individuals across the United States. The ongoing demand and innovation in biobanking practices present both opportunities and challenges, ultimately shaping the future landscape of the market as it strives to meet healthcare needs.
The Application segment of the US Tissue Banking Market plays a crucial role in addressing various medical needs and advancing Research and Development. This segment is broadly divided into Therapeutics, Medical Research, and Others, each contributing significantly to the overall market dynamics. Therapeutics represents a vital area as it utilizes tissue samples for treatment interventions, improving patient outcomes through personalized medicine.
Medical Research significantly leverages these biological materials in clinical and laboratory settings, fostering innovations in drug discovery and regenerative medicine. The Others category encompasses diverse applications, including educational and forensic purposes, broadening the utilization of tissue banks.
Given the growing demand for enhanced healthcare solutions, the US Tissue Banking Market is experiencing a marked growth trend, driven by technological advancements and increasing investments in biomedical research. Regulatory support and an increasing number of clinical trials are also fueling opportunities within this sector, highlighting the vital contributions of the Application segment in shaping the future of healthcare. Overall, this segment offers a rich landscape for market growth and development, emphasizing the importance of tissue banking in driving medical progress.
The US Tissue Banking Market is characterized by a dynamic landscape where various companies compete to offer high-quality tissue products and services for medical applications, including regenerative medicine, transplantation, and research. This market involves the storage, processing, and distribution of human tissues, which have become increasingly vital in enhancing surgical outcomes and patient care.
Key competitive factors include technological advancements in biobanking processes, regulatory compliance, supply chain efficiency, and strategic partnerships that enhance market presence. Companies invest in research and development to innovate and expand their product offerings, ensuring they meet the growing needs of healthcare providers and patients. The interplay between established players and emerging startups fosters a competitive environment that propels overall market growth.
Organogenesis holds a notable position in the US Tissue Banking Market, distinguished by its commitment to regenerative medicine. The company has developed a portfolio of advanced wound care products that utilize human tissues to promote healing and tissue regeneration. Its strength lies in its focus on high-quality processing methods and adherence to regulatory standards, which has earned it a strong reputation amongst healthcare professionals.
Organogenesis also leverages its strong customer relationships and extensive distribution network to enhance its presence in the market. The company places particular emphasis on research, contributing significantly to the understanding and applications of human tissue in medical practices, thereby reinforcing its competitive edge.
Ellen F. Rosenberg Tissue Bank provides a specialized focus within the US Tissue Banking Market, concentrating on the collection and distribution of human tissues for various medical and research purposes. The organization offers key services that include the procurement of tissues, rigorous testing for quality assurance, and ethical distribution to healthcare facilities and research institutions.
Its strengths are rooted in its established relationships with donors and medical professionals, creating a reliable supply chain for human tissues. Ellen F. Rosenberg Tissue Bank has a strong presence in the academic and medical communities, underscoring its role in advancing research initiatives that benefit patient care. Furthermore, the bank actively seeks collaborations and partnerships that align with its mission to enhance tissue research, further solidifying its position in this competitive market.
Recent developments in the US Tissue Banking Market indicate a growing emphasis on regenerative medicine and advanced therapies. Companies like Organogenesis and LifeNet Health are leading innovations in wound care and orthopedic applications through enhanced tissue grafting techniques. In addition, the American Red Cross has made strides in expanding its tissue banking capabilities, focusing on bone and soft tissue preservation for transplant purposes.
In terms of mergers and acquisitions, Novartis AG announced its acquisition of a biotechnology firm with a strong portfolio in tissue engineering in July 2023, indicating an escalating interest in biologics that support tissue regeneration. Furthermore, Ellen F. Rosenberg Tissue Bank is collaborating with leading research institutions to enhance its catalog of human tissue samples, improving accessibility for clinical trials.
Market valuations have surged as stakeholders invest in Research and Development to boost technology enhancements in cryopreservation and tissue processing, illustrating the ongoing commitment to tissue banking solutions. Notably, the span of the last two to three years has seen significant regulatory advancements affecting tissue bank operations, reflecting the industry's response to ethical considerations and the demand for quality assurance.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 357.7(USD Million) |
| MARKET SIZE 2024 | 390.0(USD Million) |
| MARKET SIZE 2035 | 1070.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.609% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Organogenesis, Ellen F. Rosenberg Tissue Bank, Novartis AG, Tissue Solutions, LifeNet Health, Regeneron Pharmaceuticals, AlloSource, Tissue Regeneration, Mayo Clinic, Connective Tissue Regeneration, CryoLife, American Red Cross, STEMCELL Technologies, Tissue Banks International, Biologics, LLC |
| SEGMENTS COVERED | Type, Tissue Type, Application |
| KEY MARKET OPPORTUNITIES | Expanding regenerative medicine applications, Increasing organ transplant demand, Advancements in storage technologies, Growth in personalized medicine, Rising biobanking collaborations |
| KEY MARKET DYNAMICS | rising demand for transplantation, increasing government regulations, advancements in preservation technologies, growing public awareness, expanding research applications |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Tissue Banking Market is projected to be valued at 390.0 million USD in 2024.
By 2035, the US Tissue Banking Market is expected to reach a value of 1070.0 million USD.
The expected CAGR for the US Tissue Banking Market from 2025 to 2035 is 9.609 percent.
The Media and Consumable segment is valued at 320.0 million USD by 2035, indicating significant growth.
Major players include Organogenesis, Mayo Clinic, LifeNet Health, and Novartis AG, among others.
The Cryopreservation Equipment segment of the US Tissue Banking Market is valued at 100.0 million USD in 2024.
The Thawing Equipment segment is projected to be valued at 150.0 million USD by 2035.
In 2024, the Quality Control Equipment segment is valued at 70.0 million USD.
Challenges may include regulatory hurdles and ethical concerns surrounding tissue donation.
Emerging trends include advancements in technology and increased demand for regenerative medicine.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
